![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1313522 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of L3MBTL3 mRNA | CTD | PMID:22079256 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of L3MBTL3 mRNA | CTD | PMID:20068009 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | RGD:1313522 | 6480464 | Dihydrotestosterone results in increased expression of L3MBTL3 mRNA | CTD | PMID:29581250 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1313523 | 6480464 | Tetrachlorodibenzodioxin affects the expression of L3MBTL3 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of L3MBTL3 mRNA | CTD | PMID:33387578 | 2,4-diaminotoluene | decreases expression | ISO | RGD:1313523 | 6480464 | 2, 4-diaminotoluene results in decreased expression of L3MBTL3 mRNA | CTD | PMID:20713471 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 6-dinitrotoluene affects the expression of L3MBTL3 mRNA | CTD | PMID:21346803 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1313522 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of L3MBTL3 mRNA | CTD | PMID:28628672 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1313523 | 6480464 | Fenretinide results in decreased expression of L3MBTL3 mRNA | CTD | PMID:28973697 | 8-Br-cAMP | decreases expression | ISO | RGD:1313522 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of L3MBTL3 mRNA | CTD | PMID:22079614 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of L3MBTL3 mRNA | CTD | PMID:28959563 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of L3MBTL3 mRNA | CTD | PMID:30779732 | benzo[a]pyrene | affects methylation | ISO | RGD:1313522 | 6480464 | Benzo(a)pyrene affects the methylation of L3MBTL3 5' UTR, Benzo(a)pyrene affects the methylation of L3MBTL3 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | RGD:1313523 | 6480464 | Benzo(a)pyrene results in increased methylation of L3MBTL3 intron | CTD | PMID:27901495 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of L3MBTL3 mRNA | CTD | PMID:30816183 | bisphenol A | increases expression | ISO | RGD:1313523 | 6480464 | bisphenol A results in increased expression of L3MBTL3 mRNA | CTD | PMID:35479511 | bisphenol A | decreases expression | ISO | RGD:1313523 | 6480464 | bisphenol A results in decreased expression of L3MBTL3 mRNA | CTD | PMID:33221593 | bisphenol A | increases expression | ISO | RGD:1313522 | 6480464 | bisphenol A results in increased expression of L3MBTL3 mRNA | CTD | PMID:29275510 | bisphenol A | multiple interactions | ISO | RGD:1313522 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of L3MBTL3 mRNA | CTD | PMID:28628672 | bisphenol A | decreases expression | ISO | RGD:1313522 | 6480464 | bisphenol A results in decreased expression of L3MBTL3 mRNA | CTD | PMID:31715268 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of L3MBTL3 promoter | CTD | PMID:22457795 | calcitriol | decreases expression | ISO | RGD:1313522 | 6480464 | Calcitriol results in decreased expression of L3MBTL3 mRNA | CTD | PMID:16002434 | cobalt dichloride | decreases expression | ISO | RGD:1313522 | 6480464 | cobaltous chloride results in decreased expression of L3MBTL3 mRNA | CTD | PMID:19320972 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of L3MBTL3 mRNA | CTD | PMID:24386269 | dexamethasone | multiple interactions | ISO | RGD:1313522 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of L3MBTL3 mRNA | CTD | PMID:28628672 | dimethylarsinic acid | multiple interactions | ISO | RGD:1313523 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA | CTD | PMID:34876320 | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of L3MBTL3 mRNA | CTD | PMID:24793618 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of L3MBTL3 mRNA | CTD | PMID:22061828 | indometacin | multiple interactions | ISO | RGD:1313522 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of L3MBTL3 mRNA | CTD | PMID:28628672 | lipopolysaccharide | multiple interactions | ISO | RGD:1313522 | 6480464 | [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of L3MBTL3 mRNA | CTD | PMID:35811015 | methyl methanesulfonate | decreases expression | ISO | RGD:1313522 | 6480464 | Methyl Methanesulfonate results in decreased expression of L3MBTL3 mRNA | CTD | PMID:23649840 | methylarsonic acid | multiple interactions | ISO | RGD:1313523 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA | CTD | PMID:34876320 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of L3MBTL3 mRNA | CTD | PMID:25729387 | p-toluidine | decreases expression | EXP | | 6480464 | 4-toluidine results in decreased expression of L3MBTL3 mRNA | CTD | PMID:27638505 | paracetamol | affects expression | ISO | RGD:1313523 | 6480464 | Acetaminophen affects the expression of L3MBTL3 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of L3MBTL3 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | RGD:1313522 | 6480464 | Acetaminophen results in decreased expression of L3MBTL3 mRNA | CTD | PMID:29067470 | phenobarbital | affects expression | ISO | RGD:1313523 | 6480464 | Phenobarbital affects the expression of L3MBTL3 mRNA | CTD | PMID:23091169 | potassium chromate | decreases expression | ISO | RGD:1313522 | 6480464 | potassium chromate(VI) results in decreased expression of L3MBTL3 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | RGD:1313522 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of L3MBTL3 mRNA | CTD | PMID:22079256 | protein kinase inhibitor | multiple interactions | ISO | RGD:1313522 | 6480464 | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of L3MBTL3 mRNA] | CTD | PMID:28003376 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | RGD:1313522 | 6480464 | [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of L3MBTL3 mRNA | CTD | PMID:35811015 | sodium arsenate | multiple interactions | ISO | RGD:1313523 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA | CTD | PMID:34876320 | sodium arsenite | decreases expression | ISO | RGD:1313522 | 6480464 | sodium arsenite results in decreased expression of L3MBTL3 mRNA | CTD | PMID:25879800 | sodium arsenite | multiple interactions | ISO | RGD:1313523 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA | CTD | PMID:34876320 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of L3MBTL3 mRNA | CTD | PMID:34492290 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of L3MBTL3 mRNA | CTD | PMID:25729387 | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of L3MBTL3 gene | CTD | PMID:27618143 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of L3MBTL3 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | RGD:1313522 | 6480464 | trichostatin A results in increased expression of L3MBTL3 mRNA | CTD | PMID:24935251 | tungsten | decreases expression | ISO | RGD:1313523 | 6480464 | Tungsten results in decreased expression of L3MBTL3 mRNA | CTD | PMID:30912803 | urethane | decreases expression | ISO | RGD:1313522 | 6480464 | Urethane results in decreased expression of L3MBTL3 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | RGD:1313522 | 6480464 | Valproic Acid results in decreased expression of L3MBTL3 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | RGD:1313522 | 6480464 | Valproic Acid affects the expression of L3MBTL3 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | RGD:1313522 | 6480464 | Valproic Acid results in increased expression of L3MBTL3 mRNA | CTD | PMID:24935251, PMID:29154799 | valproic acid | increases methylation | ISO | RGD:1313522 | 6480464 | Valproic Acid results in increased methylation of L3MBTL3 gene | CTD | PMID:29154799 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of L3MBTL3 mRNA | CTD | PMID:23555832 | zoledronic acid | decreases expression | ISO | RGD:1313522 | 6480464 | zoledronic acid results in decreased expression of L3MBTL3 mRNA | CTD | PMID:24714768 | |